Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Scleromyxedema without monoclonal gammopathy is a form of atypical lichen myxedematosus, characterized by a generalized sclerodermoid infiltration of skin studded with multiple, firm papules of 1-3 mm in diameter involving face (leonine appearance), trunk, and limbs, without monoclonal gammopathy. The involvement of the face can be missing and pruritus may be prominent.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for scleromyxedema without monoclonal gammopathy.
26 publications have been identified in PubMed for scleromyxedema without monoclonal gammopathy. Research spans Case Report / Case Series (65%), Review / Meta-Analysis (23%), and Gene Therapy / Novel Therapeutics (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 17 | 65% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
6 |
23% |
New treatment approaches | 2 | 8% |
Clinical study results | 1 | 4% |
Adam Z (2026). [PMID: 42172113](https://pubmed.ncbi.nlm.nih.gov/42172113/). *Klin Onkol*. [Review / Meta-Analysis]
Ajmani A (2026). [PMID: 41675018](https://pubmed.ncbi.nlm.nih.gov/41675018/). *JAAD case reports*. [Case Report / Case Series]
Kassalow B (2026). [PMID: 42200852](https://pubmed.ncbi.nlm.nih.gov/42200852/). *Reports (MDPI)*. [Case Report / Case Series]
Mir TH (2026). [PMID: 41740896](https://pubmed.ncbi.nlm.nih.gov/41740896/). *Journal of the American Academy of Dermatology*. [Review / Meta-Analysis]
Negele N (2026). [PMID: 41978975](https://pubmed.ncbi.nlm.nih.gov/41978975/). *Dermatol Reports*. [Gene Therapy / Novel Therapeutics]
Peri K (2026). [PMID: 41625143](https://pubmed.ncbi.nlm.nih.gov/41625143/). *SAGE open medical case reports*. [Case Report / Case Series]
Rogowska J (2025). [PMID: 39777523](https://pubmed.ncbi.nlm.nih.gov/39777523/). *Rheumatology international*. [Review / Meta-Analysis]
Gao A (2025). [PMID: 39872227](https://pubmed.ncbi.nlm.nih.gov/39872227/). *Clinical, cosmetic and investigational dermatology*. [Case Report / Case Series]
Soontrapa P (2025). [PMID: 40921022](https://pubmed.ncbi.nlm.nih.gov/40921022/). *Neurology*. [Review / Meta-Analysis]
Theves F (2025). [PMID: 39082873](https://pubmed.ncbi.nlm.nih.gov/39082873/). *Journal of the European Academy of Dermatology and Venereology : JEADV*. [Case Report / Case Series]